Federal inspectors found an open Insulin Lispro pen in the medication cart designated for Resident 5 at Altercare Newark South on November 20. The resident's physician had ordered Insulin Aspart, a different fast-acting insulin with a quicker onset time.
The medication error went undetected despite daily administration. Nursing staff documented on medication records throughout November that they were giving the resident Insulin Aspart as prescribed. In reality, they were administering Insulin Lispro from a pen that belonged to the resident but was never ordered by doctors.
Resident 5 was admitted to the 43-bed facility on August 14 with multiple serious conditions including acute respiratory failure with hypercapnia, muscle weakness, difficulty swallowing, Type II diabetes, hypertension, and atherosclerotic heart disease. The resident's care plan indicated assistance was needed with medication administration.
The physician's order specified Insulin Aspart U-100 insulin pen, 6 units administered subcutaneously before meals at 8:00 AM, 12:00 PM, and 5:00 PM, with instructions to hold the dose if blood sugar dropped below 150. The order was dated August 14, the day of admission.
Medical records contained no physician order for Insulin Lispro.
Both medications are fast-acting insulins, but they work at different speeds. Insulin Aspart begins working within five to 10 minutes of injection. Insulin Lispro takes 15 minutes to take effect. For diabetic patients managing blood sugar around meals, the timing difference can affect glucose control.
When inspectors observed the medication cart on November 20 at 9:04 AM, they found the Insulin Lispro pen was already opened and showed signs of use. Assistant Director of Nursing 230 confirmed during the inspection that the pen belonged to Resident 5 and had been used to provide insulin to the resident.
The medication administration records for November showed a pattern of staff signing off on doses three times daily. Each entry indicated they were administering the prescribed Insulin Aspart before meals, with notations about holding doses when blood sugar readings fell below the threshold.
The facility's medication administration system failed to catch the substitution. Staff were documenting administration of one medication while actually giving another, creating a false record of compliance with physician orders.
The inspection occurred following a complaint to state regulators. Federal rules require nursing homes to provide pharmaceutical services that meet each resident's needs and to employ or obtain services from licensed pharmacists to oversee medication safety.
Resident 5's multiple medical conditions made accurate medication administration particularly critical. Acute respiratory failure with hypercapnia indicates the resident had difficulty breathing and retaining carbon dioxide. Combined with diabetes, heart disease, and swallowing difficulties, any medication errors could compound existing health risks.
The facility census was 43 residents at the time of inspection. Inspectors reviewed medication practices for three residents and found the insulin error affected one of them.
Nursing homes are required to follow physician orders precisely when administering medications. The substitution of one insulin type for another, even within the same category of fast-acting insulins, represents a deviation from prescribed treatment that could affect a diabetic resident's blood sugar management.
The medication error continued for months without detection by nursing staff, pharmacy consultants, or facility administrators responsible for overseeing resident care. The discovery came only when federal inspectors physically examined the medication cart during their November inspection.
Staff had been signing medication records indicating proper administration of the prescribed insulin while simultaneously using an unprescribed medication pen. The documentation created an appearance of compliance while the actual medication administration violated the physician's treatment plan.
The facility's failure affected a vulnerable resident managing multiple serious medical conditions requiring precise medication timing and dosing. The insulin mix-up occurred during a period when the resident needed consistent blood sugar control to support recovery from respiratory failure and management of heart disease.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Altercare Newark South Inc. from 2025-11-24 including all violations, facility responses, and corrective action plans.